First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Short Interest Update

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) saw a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 22,381 shares, a growth of 28.1% from the March 15th total of 17,467 shares. Based on an average trading volume of 49,870 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.2% of the shares of the stock are sold short.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Large investors have recently modified their holdings of the company. High Point Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at approximately $26,000. Russell Investments Group Ltd. lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after purchasing an additional 158 shares during the last quarter. Rossby Financial LCC lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock valued at $31,000 after purchasing an additional 104 shares during the last quarter. AG Campbell Advisory LLC bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter valued at approximately $31,000. Finally, Capital Investment Advisory Services LLC lifted its position in First Trust NYSE Arca Biotechnology Index Fund by 63.1% during the third quarter. Capital Investment Advisory Services LLC now owns 181 shares of the company’s stock valued at $32,000 after purchasing an additional 70 shares during the last quarter.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.0%

FBT stock opened at $208.73 on Thursday. The firm has a 50 day moving average of $202.47 and a 200-day moving average of $203.21. First Trust NYSE Arca Biotechnology Index Fund has a 12 month low of $150.22 and a 12 month high of $224.94. The firm has a market capitalization of $2.36 billion, a P/E ratio of 21.72 and a beta of 0.70.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.